|
| ID |
DDInter1548 |
| Drug Type |
small molecule |
| Molecular Formula |
C9H13N2O2 |
| Molecular Weight |
181.215
|
| Description |
Pyridostigmine is a cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants.
|
| ATC Classification |
N07AA02
|
| IUPAC Name |
3-[(Dimethylcarbamoyl)Oxy]-1-Methylpyridin-1-Ium |
| InChI |
Inchi=1S/C9H13N2O2/C1-10(2)9(12)13-8-5-4-6-11(3)7-8/H4-7H,1-3H3/Q+1 |
| InChI Key |
RVOLLAQWKVFTGE-UHFFFAOYSA-N |
| Canonical SMILES |
CN(C)C(=O)OC1=C[N+](C)=CC=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|